GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (XPAR:ALMDP) » Definitions » Net Margin %

Medesis Pharma (XPAR:ALMDP) Net Margin % : -2,551.61% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medesis Pharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Medesis Pharma's Net Income for the six months ended in Jun. 2024 was €-0.79 Mil. Medesis Pharma's Revenue for the six months ended in Jun. 2024 was €0.03 Mil. Therefore, Medesis Pharma's net margin for the quarter that ended in Jun. 2024 was -2,551.61%.

The historical rank and industry rank for Medesis Pharma's Net Margin % or its related term are showing as below:

XPAR:ALMDP' s Net Margin % Range Over the Past 10 Years
Min: -9290.91   Med: -2038.48   Max: -378.47
Current: -4974.6


XPAR:ALMDP's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -110.97 vs XPAR:ALMDP: -4974.60

Medesis Pharma Net Margin % Historical Data

The historical data trend for Medesis Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma Net Margin % Chart

Medesis Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial -837.83 -378.47 -2,757.29 -5,848.94 -1,319.67

Medesis Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -4,372.22 -10,672.73 -602.99 -7,321.88 -2,551.61

Competitive Comparison of Medesis Pharma's Net Margin %

For the Biotechnology subindustry, Medesis Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medesis Pharma's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medesis Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Medesis Pharma's Net Margin % falls into.


;
;

Medesis Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Medesis Pharma's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-3.959/0.3
=-1,319.67 %

Medesis Pharma's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin=Net Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.791/0.031
=-2,551.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medesis Pharma  (XPAR:ALMDP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Medesis Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medesis Pharma Business Description

Traded in Other Exchanges
N/A
Address
Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670
Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines